221 related articles for article (PubMed ID: 31796951)
1. Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy.
Anderson JL; Khoury G; Fromentin R; Solomon A; Chomont N; Sinclair E; Milush JM; Hartogensis W; Bacchetti P; Roche M; Tumpach C; Gartner M; Pitman MC; Epling CL; Hoh R; Hecht FM; Somsouk M; Cameron PU; Deeks SG; Lewin SR
J Infect Dis; 2020 Feb; 221(5):744-755. PubMed ID: 31796951
[TBL] [Abstract][Full Text] [Related]
2. Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.
Khoury G; Anderson JL; Fromentin R; Hartogenesis W; Smith MZ; Bacchetti P; Hecht FM; Chomont N; Cameron PU; Deeks SG; Lewin SR
AIDS; 2016 Jun; 30(10):1511-20. PubMed ID: 26807971
[TBL] [Abstract][Full Text] [Related]
3. Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
Khoury G; Fromentin R; Solomon A; Hartogensis W; Killian M; Hoh R; Somsouk M; Hunt PW; Girling V; Sinclair E; Bacchetti P; Anderson JL; Hecht FM; Deeks SG; Cameron PU; Chomont N; Lewin SR
J Infect Dis; 2017 Mar; 215(6):911-919. PubMed ID: 28453847
[TBL] [Abstract][Full Text] [Related]
4. HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy.
Gosselin A; Wiche Salinas TR; Planas D; Wacleche VS; Zhang Y; Fromentin R; Chomont N; Cohen ÉA; Shacklett B; Mehraj V; Ghali MP; Routy JP; Ancuta P
AIDS; 2017 Jan; 31(1):35-48. PubMed ID: 27835617
[TBL] [Abstract][Full Text] [Related]
5. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
[TBL] [Abstract][Full Text] [Related]
6. Blood CXCR3
Banga R; Procopio FA; Ruggiero A; Noto A; Ohmiti K; Cavassini M; Corpataux JM; Paxton WA; Pollakis G; Perreau M
Front Immunol; 2018; 9():144. PubMed ID: 29459864
[TBL] [Abstract][Full Text] [Related]
7. The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence.
Yukl SA; Shergill AK; Ho T; Killian M; Girling V; Epling L; Li P; Wong LK; Crouch P; Deeks SG; Havlir DV; McQuaid K; Sinclair E; Wong JK
J Infect Dis; 2013 Oct; 208(8):1212-20. PubMed ID: 23852128
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection.
Gosselin A; Monteiro P; Chomont N; Diaz-Griffero F; Said EA; Fonseca S; Wacleche V; El-Far M; Boulassel MR; Routy JP; Sekaly RP; Ancuta P
J Immunol; 2010 Feb; 184(3):1604-16. PubMed ID: 20042588
[TBL] [Abstract][Full Text] [Related]
9. CD32
Noto A; Procopio FA; Banga R; Suffiotti M; Corpataux JM; Cavassini M; Riva A; Fenwick C; Gottardo R; Perreau M; Pantaleo G
J Virol; 2018 Oct; 92(20):. PubMed ID: 29976671
[TBL] [Abstract][Full Text] [Related]
10. Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites.
Lee E; von Stockenstrom S; Morcilla V; Odevall L; Hiener B; Shao W; Hartogensis W; Bacchetti P; Milush J; Liegler T; Sinclair E; Hatano H; Hoh R; Somsouk M; Hunt P; Boritz E; Douek D; Fromentin R; Chomont N; Deeks SG; Hecht FM; Palmer S
J Virol; 2020 Jan; 94(3):. PubMed ID: 31723024
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 DNA and Immune Activation Levels Differ for Long-Lived T-Cells in Lymph Nodes, Compared with Peripheral Blood, during Antiretroviral Therapy.
Mallarino-Haeger C; Pino M; Viox EG; Pagliuzza A; King CT; Nguyen K; Harper JL; Aldrete SDM; Cervasi B; Delman KA; Lowe MC; Chomont N; Marconi VC; Paiardini M
J Virol; 2023 Apr; 97(4):e0167022. PubMed ID: 36971588
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymph-node CD4+ T cells.
Stellbrink HJ; van Lunzen J; Hufert FT; Fröschle G; Wolf-Vorbeck G; Zöllner B; Albrecht H; Greten H; Racz P; Tenner-Racz K
AIDS; 1997 Jul; 11(9):1103-10. PubMed ID: 9233456
[TBL] [Abstract][Full Text] [Related]
13. Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin β7.
Monteiro P; Gosselin A; Wacleche VS; El-Far M; Said EA; Kared H; Grandvaux N; Boulassel MR; Routy JP; Ancuta P
J Immunol; 2011 Apr; 186(8):4618-30. PubMed ID: 21398606
[TBL] [Abstract][Full Text] [Related]
14. HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy.
Costiniuk CT; Salahuddin S; Farnos O; Olivenstein R; Pagliuzza A; Orlova M; Schurr E; De Castro C; Bourbeau J; Routy JP; Ancuta P; Chomont N; Jenabian MA
AIDS; 2018 Oct; 32(16):2279-2289. PubMed ID: 30102653
[TBL] [Abstract][Full Text] [Related]
15. CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.
Abdel-Mohsen M; Kuri-Cervantes L; Grau-Exposito J; Spivak AM; Nell RA; Tomescu C; Vadrevu SK; Giron LB; Serra-Peinado C; Genescà M; Castellví J; Wu G; Del Rio Estrada PM; González-Navarro M; Lynn K; King CT; Vemula S; Cox K; Wan Y; Li Q; Mounzer K; Kostman J; Frank I; Paiardini M; Hazuda D; Reyes-Terán G; Richman D; Howell B; Tebas P; Martinez-Picado J; Planelles V; Buzon MJ; Betts MR; Montaner LJ
Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669853
[TBL] [Abstract][Full Text] [Related]
16. Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4
Jones BR; Miller RL; Kinloch NN; Tsai O; Rigsby H; Sudderuddin H; Shahid A; Ganase B; Brumme CJ; Harris M; Poon AFY; Brockman MA; Fromentin R; Chomont N; Joy JB; Brumme ZL
J Virol; 2020 Feb; 94(5):. PubMed ID: 31776273
[TBL] [Abstract][Full Text] [Related]
17. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
18. New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy.
Wacleche VS; Goulet JP; Gosselin A; Monteiro P; Soudeyns H; Fromentin R; Jenabian MA; Vartanian S; Deeks SG; Chomont N; Routy JP; Ancuta P
Retrovirology; 2016 Aug; 13(1):59. PubMed ID: 27553844
[TBL] [Abstract][Full Text] [Related]
19. LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy.
Planas D; Pagliuzza A; Ponte R; Fert A; Marchand LR; Massanella M; Gosselin A; Mehraj V; Dupuy FP; Isnard S; Goulet JP; Lesage S; Cohen EA; Ghali MP; Angel JB; Chomont N; Routy JP; Ancuta P
EBioMedicine; 2021 Mar; 65():103270. PubMed ID: 33662832
[TBL] [Abstract][Full Text] [Related]
20. Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.
Bolduc JF; Ouellet M; Hany L; Tremblay MJ
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
